Literature DB >> 32238465

HIF-1α: a potential treatment target in chronic lymphocytic leukemia.

Martina Seiffert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32238465      PMCID： PMC7109720          DOI： 10.3324/haematol.2019.246330

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL.

Authors:  Deyan Yordanov Yosifov; Irina Idler; Nupur Bhattacharya; Michaela Reichenzeller; Viola Close; Daria Ezerina; Annika Scheffold; Billy Michael Chelliah Jebaraj; Sabrina Kugler; Johannes Bloehdorn; Jasmin Bahlo; Sandra Robrecht; Barbara Eichhorst; Kirsten Fischer; Anja Weigel; Hauke Busch; Peter Lichter; Hartmut Döhner; Tobias P Dick; Stephan Stilgenbauer; Daniel Mertens
Journal:  Leukemia       Date:  2019-07-12       Impact factor: 11.528

Review 2.  Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.

Authors:  Bola S Hanna; Selcen Öztürk; Martina Seiffert
Journal:  Mol Immunol       Date:  2017-11-22       Impact factor: 4.407

Review 3.  The role of p53 in hypoxia-induced apoptosis.

Authors:  Ester M Hammond; Amato J Giaccia
Journal:  Biochem Biophys Res Commun       Date:  2005-06-10       Impact factor: 3.575

4.  HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.

Authors:  Roberta Valsecchi; Nadia Coltella; Daniela Belloni; Manfredi Ponente; Elisa Ten Hacken; Cristina Scielzo; Lydia Scarfò; Maria Teresa Sabrina Bertilaccio; Paola Brambilla; Elisa Lenti; Filippo Martinelli Boneschi; Andrea Brendolan; Elisabetta Ferrero; Marina Ferrarini; Paolo Ghia; Giovanni Tonon; Maurilio Ponzoni; Federico Caligaris-Cappio; Rosa Bernardi
Journal:  Blood       Date:  2016-01-29       Impact factor: 22.113

5.  BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.

Authors:  Peter Ellinghaus; Iring Heisler; Kerstin Unterschemmann; Michael Haerter; Hartmut Beck; Susanne Greschat; Alexander Ehrmann; Holger Summer; Ingo Flamme; Felix Oehme; Karlheinz Thierauch; Martin Michels; Holger Hess-Stumpp; Karl Ziegelbauer
Journal:  Cancer Med       Date:  2013-08-20       Impact factor: 4.452

6.  Metabolic plasticity in CLL: adaptation to the hypoxic niche.

Authors:  K M Koczula; C Ludwig; R Hayden; L Cronin; G Pratt; H Parry; D Tennant; M Drayson; C M Bunce; F L Khanim; U L Günther
Journal:  Leukemia       Date:  2015-07-23       Impact factor: 11.528

7.  HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.

Authors:  Valentina Griggio; Candida Vitale; Maria Todaro; Chiara Riganti; Joanna Kopecka; Chiara Salvetti; Riccardo Bomben; Michele Dal Bo; Daniela Magliulo; Davide Rossi; Gabriele Pozzato; Lisa Bonello; Monia Marchetti; Paola Omedè; Ahad Ahmed Kodipad; Luca Laurenti; Giovanni Del Poeta; Francesca Romana Mauro; Rosa Bernardi; Thorsten Zenz; Valter Gattei; Gianluca Gaidano; Robin Foà; Massimo Massaia; Mario Boccadoro; Marta Coscia
Journal:  Haematologica       Date:  2019-07-09       Impact factor: 9.941

8.  HIF-transcribed p53 chaperones HIF-1α.

Authors:  Esha Madan; Taylor M Parker; Christopher J Pelham; Antonio M Palma; Maria L Peixoto; Masaki Nagane; Aliya Chandaria; Ana R Tomás; Rita Canas-Marques; Vanessa Henriques; Antonio Galzerano; Joaquim Cabral-Teixeira; Karuppaiyah Selvendiran; Periannan Kuppusamy; Carlos Carvalho; Antonio Beltran; Eduardo Moreno; Uttam K Pati; Rajan Gogna
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

9.  Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth.

Authors:  Andrea Glasauer; Farhan Basit; Laura Schöckel; Katharina Bitschar; Hoa Truong; Gerrit Erdmann; Carolyn Algire; Andrea Hägebarth; Peter Hgm Willems; Charlotte Kopitz; Werner Jh Koopman; Mélanie Héroult
Journal:  Cancer Metab       Date:  2015-10-20

10.  Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.

Authors:  Eugen Tausch; Philipp Beck; Richard F Schlenk; Billy J Jebaraj; Anna Dolnik; Deyan Y Yosifov; Peter Hillmen; Fritz Offner; Ann Janssens; Govind K Babu; Sebastian Grosicki; Jiri Mayer; Panagiotis Panagiotidis; Astrid McKeown; Ira V Gupta; Alexandra Skorupa; Celine Pallaud; Lars Bullinger; Daniel Mertens; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941
View more
  1 in total

1.  Roles of lncRNA LVBU in regulating urea cycle/polyamine synthesis axis to promote colorectal carcinoma progression.

Authors:  Xiangqi Meng; Jingxuan Peng; Xiaoshan Xie; Fenghai Yu; Wencong Wang; Qihao Pan; Huilin Jin; Xiaoling Huang; Hongyan Yu; Shengrong Li; Dianying Feng; Qingxin Liu; Lekun Fang; Mong-Hong Lee
Journal:  Oncogene       Date:  2022-07-29       Impact factor: 8.756
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.